Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

JOURNAL ARTICLE published August 2021 in The Lancet Oncology

Research funded by Deutsche Krebshilfe (70113450)

Authors: Carsten Denkert | Fenja Seither | Andreas Schneeweiss | Theresa Link | Jens-Uwe Blohmer | Marianne Just | Pauline Wimberger | Almuth Forberger | Hans Tesch | Christian Jackisch | Sabine Schmatloch | Mattea Reinisch | Erich F Solomayer | Wolfgang D Schmitt | Claus Hanusch | Peter A Fasching | Kristina Lübbe | Christine Solbach | Jens Huober | Kerstin Rhiem | Frederik Marmé | Toralf Reimer | Marcus Schmidt | Bruno V Sinn | Wolfgang Janni | Elmar Stickeler | Laura Michel | Oliver Stötzer | Eric Hahnen | Jenny Furlanetto | Sabine Seiler | Valentina Nekljudova | Michael Untch | Sibylle Loibl